Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET

被引:16
|
作者
Wu, Yen-Wen [3 ,4 ]
Naya, Masanao [2 ]
Tsukamoto, Takahiro [2 ]
Komatsu, Hiroshi [2 ]
Morita, Koichi [1 ]
Yoshinaga, Keiichiro [1 ]
Kuge, Yuji [1 ]
Tsutsui, Hiroyuki [2 ]
Tamaki, Nagara [1 ]
机构
[1] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan
[3] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan
关键词
carbon-11 acetate PET; dilated cardiomyopathy; ischemic cardiomyopathy; left ventricular dysfunction; myocardial oxidative metabolism;
D O I
10.1253/circj.72.786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The C-11-acetate positron emission tomography can estimate myocardial oxidative metabolism, but previous studies have only evaluated small populations and the difference between ischemic (ICM) and idiopathic dilated cardiomyopathy (DCM) has not been fully investigated. The present aims were to evaluate global and regional myocardial oxidative metabolism in a well-characterized, large population with left ventricular (LV) dysfunction in order to clarify the metabolic differences between ICM and DCM. Methods and Results Seventy-eight patients with ejection fraction (EF) <= 50% (33 ICM; 45 DCM) were compared with 14 healthy controls. Myocardial oxidative metabolism was estimated with a clearance rate constant (Kmono) and the coefficient of variation (CV) of regional Kmono. Patients with LV dysfunction had reduced Kmono and higher CV (p<0.05). In the comparison of oxidative alterations with clinical variables there was a weak correlation between Kmono and LVEF (r=0.27). Although Kmono was reduced in both ICM and DCM, CV was more pronouncedly increased in ICM (p=0.001). In multivariate analysis, the presence of left bundle branch block (LBBB) was an independent predictor of heterogeneous oxidative metabolism in DCM (R-2=0.30, p<0.0001). Conclusions Global reduction of myocardial oxidative metabolism occurred in both ICM and DCM. Heterogeneous oxidative metabolism was observed in these patients, especially those with ICM. Furthermore, LBBB was the independent predictor of heterogeneous oxidative metabolism inpatients with DCM.
引用
收藏
页码:786 / 792
页数:7
相关论文
共 50 条
  • [1] Radiosynthesis of [11C]acetate for PET imaging of myocardial oxidative metabolism in patients with dilated cardiomyopathy
    Jiang, Huailei
    Mangner, Tom
    Bronstein, Joel
    Muzik, Otto
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [2] IMPAIRED OXIDATIVE AND GLUCOSE-METABOLISM IN HYPERTROPHIC CARDIOMYOPATHY ASSESSED BY PET USING C-11 ACETATE AND FDG
    TADAMURA, E
    TAMAKI, N
    MATSUMORI, A
    KAWAMOTO, M
    TORIZUKA, T
    MAGATA, Y
    YONEKURA, Y
    NOHARA, R
    SASAYAMA, S
    KONISHI, J
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P110 - P110
  • [3] ELEVATED RIGHT VENTRICULAR OXIDATIVE METABOLISM USING C-11 ACETATE PET IN PATIENTS WITH PULMONARY HYPERTENSION
    Yoshinaga, Keiichiro
    Ohira, Hiroshi
    Tsujino, Ichizo
    Manabe, Osamu
    Katoh, Chietsugu
    Kasai, Katsuhiko
    Satoh, Takahiro
    Oyama, Noriko
    Nishimura, Masaharu
    Tamaki, Nagara
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E845 - E845
  • [4] Impaired myocardial blood flow and oxidative metabolism in hypertrophic cardiomyopathy and severe aortic stenosis: a prospective C-11 acetate PET study
    Cho, Sang-Geon
    Kim, Hyung Yoon
    Park, Ki Seong
    Kim, Jahae
    Moon, Jang Bae
    Song, Ho-Chun
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [5] CHANGES IN MYOCARDIAL MUSCARINIC RECEPTORS IN DILATED CARDIOMYOPATHY ASSESSED WITH PET AND C-11 MQNB
    LEGULUDEC, D
    COHENSOLAL, A
    DELFORGE, J
    HENRI, I
    SYROTA, A
    GOURGON, R
    MERLET, P
    CIRCULATION, 1995, 92 (08) : 1490 - 1490
  • [6] EFFECTS OF INTENSIFIED PULMONARY HYPERTENSION SPECIFIC VASODILATOR THERAPY ON MYOCARDIAL OXIDATIVE METABOLISM AASSESSED USING C-11 ACETATE PET IN PATIENTS WITH PULMONARY HYPERTENSION
    Yoshinaga, Keiichiro
    Ohira, Hiroshi
    Tsujino, Ichizo
    Manabe, Osamu
    Sato, Takahiro
    Katoh, Chietsugu
    Kasai, Katsuhiko
    Tomiyama, Yuuki
    Oyama-Manabe, Noriko
    Nishimura, Masaharu
    Tamaki, Nagara
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1002 - E1002
  • [7] Myocardial oxidative metabolism in the failing heart: The difference between myocardial infarction and dilated cardiomyopathy assessed by PET with carbon-11 acetate.
    Noriyasu, K
    Katoh, C
    Tsukamoto, T
    Morita, K
    Kuge, Y
    Kohya, T
    Kitabatake, A
    Tamaki, N
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 159P - 159P
  • [8] MYOCARDIAL OXIDATIVE-METABOLISM IN HYPERTHYROIDISM AFTER BETA-BLOCKER TREATMENT ASSESSED BY PET WITH C-11 ACETATE
    TORIZUKA, T
    TAMAKI, N
    KAWAMOTO, M
    TADAMURA, E
    MAGATA, Y
    YONEKURA, Y
    MISAKI, T
    KASAGI, K
    MORI, T
    KONISHI, J
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P155 - P156
  • [9] ACUTE EFFECTS OF DOBUTAMINE ON MYOCARDIAL OXYGEN-CONSUMPTION AND CARDIAC EFFICIENCY MEASURED USING C-11 ACETATE KINETICS IN PATIENTS WITH DILATED CARDIOMYOPATHY
    BEANLANDS, RSB
    BACH, DS
    RAYLMAN, R
    ARMSTRONG, WF
    WILSON, V
    MONTIETH, M
    MOORE, CK
    BATES, E
    SCHWAIGER, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (05) : 1389 - 1398
  • [10] Reduction of myocardial oxidative metabolism in dilated cardiomyopathy but not in remote areas in myocardial infarction
    Noriyasu, K
    Tsukamoto, T
    Morita, K
    Kageyama, H
    Mabuchi, M
    Katoh, C
    Kuge, Y
    Kitabatake, A
    Tamaki, N
    PET AND MOLECULAR IMAGING: STATE OF THE ART AND FUTURE PERSPECTIVES, 2004, 1264 : 271 - 274